Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · IEX Real-Time Price · USD
0.990
-0.010 (-1.00%)
Feb 26, 2024, 10:20 AM EST - Market open

Rapid Micro Biosystems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
17.1323.2316.0816.51
Revenue Growth (YoY)
-26.25%44.50%-2.63%-
Cost of Revenue
25.6730.9724.1516.75
Gross Profit
-8.54-7.74-8.07-0.23
Selling, General & Admin
41.8129.7115.9412.97
Research & Development
12.879.786.535.43
Operating Expenses
54.6839.4922.4718.4
Operating Income
-63.22-47.23-30.54-18.63
Interest Expense / Income
-1.782.613.452.38
Other Expense / Income
-0.0623.592.96-0.27
Pretax Income
-61.38-73.43-36.94-20.74
Income Tax
-0.580.090.130.43
Net Income
-60.81-73.52-37.08-21.17
Preferred Dividends
04.518.145.45
Net Income Common
-60.81-78.03-45.22-26.62
Shares Outstanding (Basic)
422002
Shares Outstanding (Diluted)
422002
Shares Change
114.59%5417.16%-79.34%-
EPS (Basic)
-1.43-3.94-126.11-15.34
EPS (Diluted)
-1.43-3.94-126.11-15.34
Free Cash Flow
-65.29-58.16-31.69-22.84
Free Cash Flow Per Share
-1.54-2.94-88.36-13.16
Gross Margin
-49.85%-33.32%-50.20%-1.42%
Operating Margin
-368.99%-203.31%-189.96%-112.85%
Profit Margin
-354.91%-335.88%-281.28%-161.22%
Free Cash Flow Margin
-381.06%-250.35%-197.09%-138.34%
EBITDA
-59.18-69.3-31.99-16.91
EBITDA Margin
-345.42%-298.28%-198.97%-102.40%
Depreciation & Amortization
3.981.531.511.46
EBIT
-63.16-70.83-33.5-18.37
EBIT Margin
-368.65%-304.86%-208.35%-111.25%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).